Monday, 16 November 2026Follow on 𝕏

FDA calendar

Upcoming FDA decision dates, advisory committee meetings and EU opinions, alongside recent FDA decisions and announcements. Updated automatically every day from the FDA newsroom, openFDA, the Federal Register and company announcements.

Coming up

November 2026

December 2026

January 2027

  • 21Thu
    PDUFA date
    Dyne Therapeutics Β· Zeleciment rostudirsen (DYNE-251)
    Duchenne muscular dystrophy, exon 51 Β· Accelerated approval, priority review
    NeurologyLive β†—
  • 29Fri
    PDUFA date
    Praxis Precision Medicines Β· Ulixacaltamide
    Essential tremor
    Praxis β†—
  • 30Sat
    PDUFA date
    Pharming Β· Joenja (leniolisib)
    APDS in younger children Β· Paediatric label expansion, priority review
    Rallies β†—

June 2027

Recent FDA decisions and announcements

November 2026

October 2026

  • 30Fri
    FDA approval
    FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis
    FDA press release β†—
  • 30Fri
    Advisory committee
    Dermatologic and Ophthalmic Drugs Advisory Committee
    Federal Register β†—
  • 30Fri
    FDA approval
    FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis
    FDA press release β†—
  • 27Tue
    FDA approval
    Xbrane Biopharma Ab Β· Lucamzi (ranibizumab-blrz)
    New biologic licence
    Drugs@FDA β†—
  • 22Thu
    FDA approval
    Sandoz Inc Β· Enzeevu (aflibercept-abzv)
    New biologic licence
    Drugs@FDA β†—
  • 22Thu
    FDA approval
    Formycon AG Β· Ahzantive (aflibercept-mrbb)
    New biologic licence
    Drugs@FDA β†—
  • 22Thu
    FDA approval
    Amgen Inc Β· Pavblu (aflibercept-ayyh)
    New biologic licence
    Drugs@FDA β†—
  • 22Thu
    FDA announcement
    FDA Launches New Program to Advance Neuroscience Medical Product Development
    FDA press release β†—
  • 20Tue
    FDA approval
    Glaxosmithkline LLC Β· Hibsago (bepirovirsen)
    New molecular entity, priority review
    Drugs@FDA β†—
  • 20Tue
    FDA approval
    FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
    FDA press release β†—
  • 20Tue
    FDA approval
    FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
    FDA press release β†—
  • 20Tue
    FDA announcement
    FDA Issues Final Guidance on Prescription Drug Apps and Software
    FDA press release β†—
  • 19Mon
    FDA approval
    FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery
    FDA press release β†—
  • 19Mon
    FDA approval
    FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery
    FDA press release β†—
  • 14Wed
    FDA announcement
    FDA Launches the Rare Disease Framework Initiative to Develop a Holistic, Fit-For-Purpose Framework for Rare Disease Drug Development
    FDA press release β†—
  • 14Wed
    FDA approval
    FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
    FDA press release β†—
  • 14Wed
    FDA announcement
    FDA Launches the Rare Disease Framework Initiative to Develop a Holistic, Fit-For-Purpose Framework for Rare Disease Drug Development
    FDA press release β†—
  • 9Fri
    FDA approval
    Aicuris Anti-Infect Β· Hovilpri (pritelivir mesylate)
    New molecular entity, priority review
    Drugs@FDA β†—
  • 5Mon
    FDA announcement
    FDA Seeks Public Input to Support Ibogaine Research
    FDA press release β†—
  • 1Thu
    Advisory committee
    Vaccines and Related Biological Products Advisory Committee
    Federal Register β†—

September 2026

  • 30Wed
    FDA announcement
    FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory Committees
    FDA press release β†—
  • 29Tue
    FDA announcement
    FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution Scheme
    FDA press release β†—
  • 28Mon
    FDA approval
    FDA Approves First Treatment for MCT8 Deficiency
    FDA press release β†—
  • 28Mon
    FDA approval
    Rare Thyroid Β· Emcitate (tiratricol)
    New molecular entity, priority review
    Drugs@FDA β†—
  • 25Fri
    FDA approval
    Mirum Β· Atebrioz (zilurgisertib fumarate)
    New molecular entity, priority review
    Drugs@FDA β†—
  • 23Wed
    FDA announcement
    Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse Conditions
    FDA press release β†—
  • 23Wed
    FDA approval
    Elevar Β· Lyrfigtu (lirafugratinib hydrochloride)
    New molecular entity, priority review
    Drugs@FDA β†—
  • 17Thu
    FDA approval
    FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
    FDA press release β†—
  • 16Wed
    Advisory committee
    Pediatric Advisory Committee (PAC)
    Federal Register β†—

August 2026

July 2026

  • 31Fri
    FDA approval
    Dr Reddys Labs SA Β· Zimrixby (rituximab-cdxx)
    New biologic licence
    Drugs@FDA β†—
  • 30Thu
    Advisory committee
    Cellular, Tissue, and Gene Therapies Advisory Committee
    Federal Register β†—
  • 29Wed
    Advisory committee
    Cellular, Tissue, and Gene Therapies Advisory Committee
    Federal Register β†—
  • 24Fri
    FDA approval
    Outlook Therapeutics, Inc. Β· Lytenava (bevacizumab-vikg)
    New biologic licence
    Drugs@FDA β†—